Brookings March 10, 2020
Michael E. Chernew, Leemore Dafny, and Maximilian Pany

THE PROBLEM

The United States spends a larger share of its GDP on health care than any other advanced economy. The high private sector health-care spending in the United States relative to that of other economies is driven largely by higher prices. However, there is scant evidence that high U.S. provider prices reflect better quality of care. Because market forces have not yielded competitive commercial provider prices, the authors believe policy intervention is necessary.

THE PROPOSAL

Although the United States will likely continue to rely on markets to allocate most health-care resources, market competition has not been sufficient to control commercial provider prices. In this proposal, Michael Chernew, Leemore Dafny, and Maximilian Pany discuss how price regulations could be used...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer, Pricing / Spending, Provider
Senator asks for investigation on use of algorithms in healthcare pricing
The Cost of Medical Care, Long-Term Care, and Prescription Drugs Top Older Americans’ Health-Related Concerns – With Social Security and Medicare Top of Mind
Opinion: The world is relying on the United States to get value-based drug pricing right
The world is relying on the United States to get value-based drug pricing right
Costs top health worries among older adults

Share This Article